NDC 49702-238 - Cabenuva
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49702-238
- Package NDCs from labels
- 49702-238-01, 49702-238-64, 49702-238-03, 49702-238-61
- Manufacturer
- ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cabenuva - ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Apretude - ViiV Healthcare Company | ViiV Healthcare Company | 2025-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49702-238-01 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-238-64 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-238-03 | Apretude | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 3 mL | 200 mg in 1mL | 8 |
| 49702-238-61 | Apretude | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 3 mL | 200 mg in 1mL | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49702-238 | CABENUVA (CABOTEGRAVIR AND RILPIVIRINE) KIT [VIIV HEALTHCARE COMPANY] | 14 | Unmatched | 20250416_1698baf3-f895-4c42-a1b1-e9ee3f20da36.zip |
| 49702-238 | APRETUDE (CABOTEGRAVIR) KIT [VIIV HEALTHCARE COMPANY] | 8 | Unmatched | 20250419_4338428e-43d4-4e02-ac9d-bd98e738a7da.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | The Fresh Test, LLC | cb8e182f-c23f-4f8d-9c09-24e19b2e914e | 2026-08-05 | Warnings | G2M7P15E5P |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| IDkit HP ONE | CITRIC ACID ANHYDROUS AND 13C UREA | Meridian Bioscience Israel Ltd | 8baab7a7-5d20-46ad-9c4a-762992ef6b51 | 2026-07-28 | Warnings, Adverse reactions | 2968PHW8QP |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| Polyethylene Glycol 3350 | INSTALAX POLYETHYLENE GLYCOL 3350 | Sun Pharmaceutical Industries, Inc. | 40bd1be7-de67-8dff-e063-6294a90aca95 | 2026-07-24 | Warnings | G2M7P15E5P |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | G2M7P15E5P |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Strides Pharma Inc | 77b9060f-c9ab-4047-b1f1-063956678453 | 2026-07-15 | Warnings | G2M7P15E5P |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Infant Dextrose | DEXTROSE | Henry Schein, Inc. | ce71d929-d11e-444c-bd45-e025d5172057 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Dr. Drop NMN Vital Balance (Drop No.1 Cream 90g) | NMN (NICOTINAMIDE MONONUCLEOTIDE), ECTOIN (ECTOINE) | Reedfresh Co., LTD | 55d703ca-ff9d-0dbc-e063-6294a90ab6b1 | 2026-07-05 | Warnings | 059QF0KO0R |
| clear lax | POLYETHYLENE GLYCOL 3350 | HyVee Inc | 5bcf01d8-ddf3-4e64-8d3f-3526a51a5859 | 2026-07-02 | Warnings | G2M7P15E5P |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a1d07e-0006-0c75-e063-6394a90a7acc | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |